Serum Institute to start manufacturing Sputnik vaccine in September
PTI, Jul 13, 2021, 2:24 PM IST
Credit: Reuters photo
New Delhi: Serum Institute of India (SII) will start production of Sputnik vaccine at the company’s facilities in September, Russian Direct Investment Fund (RDIF) said on Tuesday.
“The first batch of Sputnik vaccine is expected to be produced at SII’s facilities in September,” RDIF said in a statement.
The parties intend to produce over 300 million doses of the vaccine in India per year, it added.
“As part of the technical transfer process, SII has already received cell and vector samples from the Gamaleya Center. With their import approved by the Drug Controller General of India (DCGI), the cultivation process has begun,” RDIF said.
Udayavani is now on Telegram. Click here to join our channel and stay updated with the latest news.
Top News
Related Articles More
BJP predicts positive outcome in Kerala polls, anticipates defeat of key Congress candidates
Cong slams Centre over ‘delay’ in Beed-Ahmednagar railway line project in Maharashtra
Will scrap Agniveer scheme ‘brought by Modi, not Army’ if voted to power: Rahul Gandhi
HC upholds minor’s right to privacy, protects confidentiality in pregnancy termination case
Model Code of Conduct turned into ‘Modi code of conduct’ under BJP rule: Mamata
MUST WATCH
Latest Additions
BJP predicts positive outcome in Kerala polls, anticipates defeat of key Congress candidates
Cong slams Centre over ‘delay’ in Beed-Ahmednagar railway line project in Maharashtra
Slow and steady, north Karnataka voters turn up at booths
Will scrap Agniveer scheme ‘brought by Modi, not Army’ if voted to power: Rahul Gandhi
HC upholds minor’s right to privacy, protects confidentiality in pregnancy termination case